BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27109209)

  • 1. S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation.
    Hua T; Liu S; Xin X; Cai L; Shi R; Chi S; Feng D; Wang H
    Oncol Rep; 2016 Jun; 35(6):3419-26. PubMed ID: 27109209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4 participates in epithelial-mesenchymal transition in breast cancer via targeting MMP2.
    Xu H; Li M; Zhou Y; Wang F; Li X; Wang L; Fan Q
    Tumour Biol; 2016 Mar; 37(3):2925-32. PubMed ID: 26409452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
    Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
    J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen‑related receptor γ promotes the migration and metastasis of endometrial cancer cells by targeting S100A4.
    Hua T; Wang X; Chi S; Liu Y; Feng D; Zhao Y; Wang H
    Oncol Rep; 2018 Aug; 40(2):823-832. PubMed ID: 29901152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
    Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
    Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inversed Expression Patterns of S100A4 and E-Cadherin in Cervical Cancers: Implication in Epithelial-Mesenchymal Transition.
    Liu M; Liu J; Yang B; Gao X; Gao LL; Kong QY; Zhang P; Li H
    Anat Rec (Hoboken); 2017 Dec; 300(12):2184-2191. PubMed ID: 28921916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIM and SH3 protein 1 induces TGFβ-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression.
    Wang H; Shi J; Luo Y; Liao Q; Niu Y; Zhang F; Shao Z; Ding Y; Zhao L
    Clin Cancer Res; 2014 Nov; 20(22):5835-47. PubMed ID: 25252758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.
    Jin T; Zhang Z; Yang XF; Luo JS
    Asian Pac J Cancer Prev; 2015; 16(7):2883-7. PubMed ID: 25854377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
    Gründker C; Bauerschmitz G; Schubert A; Emons G
    Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells.
    Xu X; Su B; Xie C; Wei S; Zhou Y; Liu H; Dai W; Cheng P; Wang F; Xu X; Guo C
    PLoS One; 2014; 9(7):e96441. PubMed ID: 25072505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
    Zhao Y; Zhang T; Wang Q
    Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the epithelial to mesenchymal transition markers S100A4, vimentin and Snail1 in gastroesophageal junction tumors.
    Mirza A; Foster L; Valentine H; Welch I; West CM; Pritchard S
    Dis Esophagus; 2014 Jul; 27(5):485-92. PubMed ID: 23082947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis.
    Matsuzaki S; Darcha C
    Hum Reprod; 2012 Mar; 27(3):712-21. PubMed ID: 22215621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
    Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
    Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.
    Techasen A; Namwat N; Loilome W; Duangkumpha K; Puapairoj A; Saya H; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):703-11. PubMed ID: 24867797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
    Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
    Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene.
    Wang X; Sun X; Mu L; Chen W
    Cancer Invest; 2019; 37(3):134-143. PubMed ID: 30961403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.
    Jiang FZ; He YY; Wang HH; Zhang HL; Zhang J; Yan XF; Wang XJ; Che Q; Ke JQ; Chen Z; Tong H; Zhang YL; Wang FY; Li YR; Wan XP
    Oncotarget; 2015 Dec; 6(42):44660-74. PubMed ID: 26587974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
    Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
    Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.